A BILL 
To establish procedures related to the coronavirus disease 
2019 (COVID–19) in correctional facilities. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Federal Correctional 
4
Facilities COVID–19 Response Act’’. 
5
SEC. 2. DEFINITIONS. 
6
In this Act: 
7
(1) CORRECTIONAL FACILITY.—The term ‘‘cor-
8
rectional facility’’ includes— 
9
02:56 Jun 02, 2021
H2293
2 
•HR 2293 IH
(A) Federal prisons, including all prison, 
1
correctional, and detention facilities run by the 
2
Bureau of Prisons; and 
3
(B) privately owned or privately operated 
4
prison, correctional, and detention facilities con-
5
tracted by Federal entities, including the Bu-
6
reau of Prisons, to house Federal incarcerated 
7
persons. 
8
(2) CORRECTIONAL FACILITY EMPLOYEE.—The 
9
term ‘‘correctional facility employee’’ means any in-
10
dividual employed at a correctional facility housing 
11
Federal incarcerated persons, including— 
12
(A) a Federal employee; 
13
(B) an employee of a privately owned or 
14
privately operated prison, correctional, or deten-
15
tion facility contracted by a Federal entity to 
16
house Federal incarcerated persons; and 
17
(C) an employee of a private company con-
18
tracted to provide goods and services at a cor-
19
rectional facility. 
20
(3) COVID–19 DIAGNOSTIC TEST.—The term 
21
‘‘COVID–19 diagnostic test’’ mean a test— 
22
(A) that is an in vitro diagnostic product 
23
(as defined in section 809.3 of title 21, Code of 
24
Federal Regulations, or any successor thereto) 
25
02:56 Jun 02, 2021
H2293
3 
•HR 2293 IH
for the detection of SARS–CoV–2 or the diag-
1
nosis of the virus that causes COVID–19; and 
2
(B) the administration of which— 
3
(i) is approved, cleared, or authorized 
4
under section 510(k), 513, 515, or 564 of 
5
the Federal Food, Drug, and Cosmetic Act 
6
(21 U.S.C. 360(k), 360c, 360e, 360bbb–3); 
7
(ii) the developer has requested, or in-
8
tends to request, emergency use authoriza-
9
tion under section 564 of the Federal 
10
Food, Drug, and Cosmetic Act (21 U.S.C. 
11
360bbb–3), unless and until the emergency 
12
use authorization request under such sec-
13
tion 564 has been denied or the developer 
14
of such test does not submit a request 
15
under such section within a reasonable 
16
timeframe; 
17
(iii) is developed in and authorized by 
18
a State that has notified the Secretary of 
19
Health and Human Services of its inten-
20
tion to review tests intended to diagnose 
21
COVID–19; or 
22
(iv) is another test that the Secretary 
23
determines appropriate in guidance. 
24
02:56 Jun 02, 2021
H2293
4 
•HR 2293 IH
(4) 
COVID–19 
PANDEMIC.—The 
term 
1
‘‘COVID–19 pandemic’’ means the period beginning 
2
on the date of enactment of this Act and ending on 
3
the date that is 1 year after the date on which the 
4
public health emergency declaration under section 
5
319 of the Public Health Service Act (42 U.S.C. 
6
247d) with respect to COVID–19 terminates. 
7
(5) HIGH RISK INCARCERATED PERSON.—The 
8
term ‘‘high risk incarcerated person’’ means an indi-
9
vidual who meets the definition of ‘‘incarcerated per-
10
son’’ under this section who— 
11
(A) is 50 years old or older; 
12
(B) has chronic kidney disease; 
13
(C) has chronic obstructive pulmonary dis-
14
ease; 
15
(D) is immunocompromised; 
16
(E) has obesity; 
17
(F) has a heart condition, such as coro-
18
nary artery disease or cardiomyopathy; 
19
(G) has sickle cell disease; 
20
(H) has type 1 or type 2 diabetes mellitus; 
21
(I) has moderate to severe asthma; 
22
(J) has cerebrovascular disease; 
23
(K) has cystic fibrosis; 
24
02:56 Jun 02, 2021
H2293
5 
•HR 2293 IH
(L) has hypertension or high blood pres-
1
sure; 
2
(M) has a neurological condition such as 
3
dementia or Parkinson’s Disease; 
4
(N) has liver disease; 
5
(O) is pregnant; 
6
(P) has pulmonary fibrosis; 
7
(Q) has thalassemia; 
8
(R) is a smoker; 
9
(S) has a disability; or 
10
(T) meets any other characteristic identi-
11
fied by the Centers for Disease Control and 
12
Prevention as putting individuals at increased 
13
risk of developing severe illness from COVID– 
14
19. 
15
(6) INCARCERATED PERSON.—The term ‘‘incar-
16
cerated person’’ means an individual involuntarily 
17
confined or detained in a correctional facility. 
18
(7) SIGNS AND SYMPTOMS OF COVID–19.—The 
19
term ‘‘signs and symptoms of COVID–19’’ means 
20
fever or chills, cough, shortness of breath or dif-
21
ficulty breathing, fatigue, muscle or body aches, 
22
headache, new loss of taste or smell, sore throat, 
23
congestion or runny nose, nausea or vomiting, diar-
24
rhea, and any other medical condition or reaction 
25
02:56 Jun 02, 2021
H2293
6 
•HR 2293 IH
identified by the Centers for Disease Control and 
1
Prevention as being a physical reaction to the con-
2
traction of the severe acute respiratory syndrome 
3
coronavirus 2 (SARS–CoV–2). 
4
SEC. 3. MANDATED COVID–19 TESTING AND VACCINATION 
5
AT CORRECTIONAL FACILITIES. 
6
(a) TESTING OF INCARCERATED PERSONS.— 
7
(1) IN
GENERAL.—Each correctional facility 
8
shall— 
9
(A) not later than 15 days after the date 
10
of enactment of this Act— 
11
(i) provide each incarcerated person in 
12
the facility with the option to take a 
13
COVID–19 diagnostic test, regardless of 
14
whether the incarcerated person exhibits 
15
symptoms of COVID–19, at no cost to the 
16
incarcerated person; 
17
(ii) provide each incarcerated person 
18
with the results of the diagnostic test, re-
19
gardless of the results, including an inter-
20
pretation of what the test results mean in 
21
the incarcerated person’s preferred lan-
22
guage; 
23
(iii) provide each incarcerated person 
24
who tests positive for COVID–19 with nec-
25
02:56 Jun 02, 2021
H2293
7 
•HR 2293 IH
essary medical care (as outlined in the Na-
1
tional Institutes of Health COVID–19 
2
Treatment Guidelines), including COVID– 
3
19 tests to monitor recovery if indicated by 
4
the Centers for Disease Control and Pre-
5
vention, and housing in a medical isolation 
6
unit under the care of medical profes-
7
sionals, at no cost to the incarcerated per-
8
son; 
9
(iv) place each asymptomatic incarcer-
10
ated person who is exposed to a positive 
11
case in quarantine until testing is com-
12
pleted consistent with Centers for Disease 
13
Control and Prevention guidance; and 
14
(v) place each symptomatic incarcer-
15
ated person into medical isolation while 
16
awaiting test results; and 
17
(B) during the period beginning not later 
18
than 45 days after the date of enactment of 
19
this Act and ending on the last day of the 
20
COVID–19 pandemic— 
21
(i) conduct weekly COVID–19 diag-
22
nostic testing of incarcerated persons in 
23
the facility in accordance with the guide-
24
lines developed under section 6, regardless 
25
02:56 Jun 02, 2021
H2293
8 
•HR 2293 IH
of whether such incarcerated persons ex-
1
hibit symptoms of COVID–19, at no cost 
2
to incarcerated persons; 
3
(ii) conduct COVID–19 diagnostic 
4
testing for any incarcerated person with 
5
COVID–19 symptoms, or for any incarcer-
6
ated person who is a close contact of a 
7
known COVID–19 case, in accordance with 
8
the guidelines developed under section 6; 
9
(iii) provide each incarcerated person 
10
with the results of the diagnostic tests, re-
11
gardless of the results, including an inter-
12
pretation of what the test results mean in 
13
the incarcerated person’s preferred lan-
14
guage; 
15
(iv) provide each incarcerated person 
16
who tests positive for COVID–19 with nec-
17
essary medical care (as outlined in the Na-
18
tional Institutes of Health COVID–19 
19
Treatment Guidelines), including COVID– 
20
19 tests to monitor recovery if indicated by 
21
the Centers for Disease Control and Pre-
22
vention, and housing in a medical isolation 
23
unit under the care of medical profes-
24
sionals, at no cost to the incarcerated per-
25
02:56 Jun 02, 2021
H2293
9 
•HR 2293 IH
son, in accordance with the guidelines de-
1
veloped under section 6; 
2
(v) quarantine each incarcerated per-
3
son exposed to a positive COVID–19 case 
4
in accordance with the guidelines developed 
5
under section 6; and 
6
(vi) establish a procedure through 
7
which incarcerated people can opt out of 
8
COVID–19 testing, in accordance with the 
9
guidelines developed under section 6. 
10
(2) NEW ENTRANTS.—During the period begin-
11
ning not later than 45 days after the date of enact-
12
ment of this Act and ending on the last day of the 
13
COVID–19 pandemic, each correctional facility 
14
shall— 
15
(A) provide each incarcerated person newly 
16
admitted or transferred to the facility with an 
17
optional COVID–19 diagnostic test within 24 
18
hours of entering the facility, regardless of 
19
whether the incarcerated person exhibits symp-
20
toms of COVID–19, at no cost to the incarcer-
21
ated person; and 
22
(B) immediately quarantine each incarcer-
23
ated person newly admitted or transferred to 
24
the facility within 24 hours of entering the fa-
25
02:56 Jun 02, 2021
H2293
10 
•HR 2293 IH
cility, consistent with Centers for Disease Con-
1
trol and Prevention guidance, until the incar-
2
cerated person has been confirmed to be nega-
3
tive for COVID–19, in accordance with the 
4
guidelines developed under section 6. 
5
(b) TESTING OF CORRECTIONAL FACILITY EMPLOY-
6
EES.— 
7
(1) IN
GENERAL.—Each correctional facility 
8
shall— 
9
(A) not later than 15 days after the date 
10
of enactment of this Act— 
11
(i) provide each correctional facility 
12
employee with a required COVID–19 diag-
13
nostic test, regardless of whether the em-
14
ployee exhibits symptoms of COVID–19, at 
15
no cost to the employee; and 
16
(ii) provide each correctional facility 
17
employee who tests positive for COVID–19 
18
with unlimited paid administrative leave 
19
for 
the 
purpose 
of 
recovering 
from 
20
COVID–19, and no cost COVID–19 diag-
21
nostic testing for the purpose of moni-
22
toring recovery if indicated by the Centers 
23
for Disease Control and Prevention, until 
24
02:56 Jun 02, 2021
H2293
11 
•HR 2293 IH
the employee tests negative for COVID–19; 
1
and 
2
(B) during the period beginning not later 
3
than 45 days after the date of enactment of 
4
this Act and ending on the last day of the 
5
COVID–19 pandemic— 
6
(i) conduct required weekly COVID– 
7
19 diagnostic testing of each correctional 
8
facility employee in the facility, in accord-
9
ance with the guidelines developed under 
10
section 6, regardless of whether the em-
11
ployee exhibits symptoms of COVID–19, at 
12
no cost to the employee; 
13
(ii) provide each correctional facility 
14
employee who tests positive for COVID–19 
15
with unlimited paid leave for the purpose 
16
of recovering from COVID–19, and no cost 
17
COVID–19 diagnostic testing for the pur-
18
pose of monitoring recovery if indicated by 
19
the Centers for Disease Control and Pre-
20
vention, until the employee tests negative 
21
for COVID–19; and 
22
(iii) provide each correctional facility 
23
employee who is exposed to a positive 
24
COVID–19 case with guaranteed paid 
25
02:56 Jun 02, 2021
H2293
12 
•HR 2293 IH
leave to quarantine, consistent with Cen-
1
ters for Disease Control and Prevention 
2
guidance, or until the employee has been 
3
confirmed to be negative for COVID–19. 
4
(c) VACCINATION
OF INCARCERATED PERSONS.— 
5
Each correctional facility shall— 
6
(1) not later than 45 days after the date of en-
7
actment of this Act— 
8
(A) begin providing each incarcerated per-
9
son in the facility with the option to take a 
10
COVID–19 vaccine; and 
11
(B) begin providing each incarcerated per-
12
son in the facility with information, offered in 
13
the incarcerated persons’ preferred language, on 
14
the type of COVID–19 vaccine offered, possible 
15
side effects of the COVID–19 vaccine, and edu-
16
cational materials on the benefits of COVID–19 
17
and other vaccinations. 
18
(d) VACCINATION OF CORRECTIONAL FACILITY EM-
19
PLOYEES.—Each correctional facility shall— 
20
(1) not later than 45 days after the date of en-
21
actment of this Act— 
22
(A) begin providing each correctional facil-
23
ity employee with the option to take a COVID– 
24
19 vaccine; and 
25
02:56 Jun 02, 2021
H2293
13 
•HR 2293 IH
(B) begin providing each correctional facil-
1
ity employee with information on the type of 
2
COVID–19 vaccine offered, possible side effects 
3
of the COVID–19 vaccine, and educational ma-
4
terials on the benefits of COVID–19 and other 
5
vaccinations. 
6
(e) PRIVACY.—Any data collected, stored, received, or 
7
published under this section shall— 
8
(1) be so collected, stored, received, or pub-
9
lished in a manner that protects the privacy of indi-
10
viduals whose information is included in the data; 
11
(2) be de-identified or anonymized in a manner 
12
that protects the identity of all individuals whose in-
13
formation is included in the data; 
14
(3) comply with privacy protections provided 
15
under the regulations promulgated under section 
16
264(c) of the Health Insurance Portability and Ac-
17
countability Act of 1996 (42 U.S.C. 1320d–2 note); 
18
and 
19
(4) be limited in use for the purpose of public 
20
health and be protected from all other internal use 
21
by any entity that collects, stores, or receives the 
22
data, including use of the data in determinations of 
23
eligibility (or continued eligibility) in health plans, 
24
and from any other inappropriate uses. 
25
02:56 Jun 02, 2021
H2293
14 
•HR 2293 IH
(f) AUTHORIZATION OF APPROPRIATIONS.—There is 
1
authorized to be appropriated to relevant medical and pub-
2
lic officials such sums as are necessary to procure and ad-
3
minister the COVID–19 diagnostic tests and provide the 
4
medical care required in this section. 
5
SEC. 4. COVID–19 DATA COLLECTION AT CORRECTIONAL 
6
FACILITIES. 
7
(a) DATA COLLECTION.—During the period begin-
8
ning not later than 45 days after the date of enactment 
9
of this Act and ending on the last day of the COVID– 
10
19 pandemic, each correctional facility shall submit weekly 
11
reports to the Department of Justice, the Centers for Dis-
12
ease Control and Prevention, and the public health author-
13
ity of the State in which the facility is located on the fol-
14
lowing: 
15
(1) TESTING NUMBERS.—COVID–19 diagnostic 
16
testing, including cumulative and new (since the pre-
17
vious report) counts of— 
18
(A) the number of incarcerated persons 
19
tested for COVID–19, disaggregated by routine 
20
weekly testing, symptomatic testing, close con-
21
tact testing, recovery monitoring testing, and 
22
new entrant testing; 
23
(B) the number of correctional facility em-
24
ployees tested for COVID–19, disaggregated by 
25
02:56 Jun 02, 2021
H2293
15 
•HR 2293 IH
routine weekly testing, symptomatic testing, 
1
close contact testing, and recovery monitoring 
2
testing; and 
3
(C) the COVID–19 diagnostic test devel-
4
oper, test name, and type of test (molecular, 
5
antigen, or other) for each COVID–19 diag-
6
nostic test conducted. 
7
(2) TEST
RESULTS.—COVID–19 diagnostic 
8
testing outcomes, including cumulative and new 
9
(since the previous report) counts of— 
10
(A) the number of confirmed active cases 
11
of COVID–19 among incarcerated persons, 
12
disaggregated by routine weekly testing, symp-
13
tomatic testing, close contact testing, recovery 
14
monitoring testing, and new entrant testing; 
15
(B) the number of confirmed negative 
16
cases of COVID–19 among incarcerated per-
17
sons, disaggregated by routine weekly testing, 
18
symptomatic testing, close contact testing, re-
19
covery monitoring testing, and new entrant 
20
testing; 
21
(C) the number of confirmed active cases 
22
of COVID–19 among correctional facility em-
23
ployees, disaggregated by routine weekly test-
24
02:56 Jun 02, 2021
H2293
16 
•HR 2293 IH
ing, symptomatic testing, close contact testing, 
1
and recovery monitoring testing; 
2
(D) the number of confirmed negative 
3
cases of COVID–19 among correctional facility 
4
employees, disaggregated by routine weekly 
5
testing, symptomatic testing, close contact test-
6
ing, and recovery monitoring testing; 
7
(E) the number of tests pending results, 
8
disaggregated by incarcerated persons and cor-
9
rectional facility employees; 
10
(F) the average time between testing an 
11
incarcerated person for COVID–19 and receiv-
12
ing the results of the test; and 
13
(G) the average time between testing a 
14
correctional facility employee for COVID–19 
15
and receiving the results of the test. 
16
(3) CASE
OUTCOMES.—COVID–19 case out-
17
comes, including cumulative and new (since the pre-
18
vious report) counts of— 
19
(A) the number of incarcerated persons 
20
hospitalized for a case of COVID–19; 
21
(B) the number of incarcerated persons 
22
who have recovered from COVID–19; 
23
02:56 Jun 02, 2021
H2293
17 
•HR 2293 IH
(C) the number of incarcerated persons 
1
currently in quarantine or medical isolation for 
2
COVID–19, respectively; 
3
(D) the number of incarcerated persons 
4
who have completed quarantine or been released 
5
from medical isolation, respectively; 
6
(E) the number of incarcerated persons 
7
who have died from a confirmed or suspected 
8
case of COVID–19; 
9
(F) the number of correctional facility em-
10
ployees hospitalized for a case of COVID–19; 
11
(G) the number of correctional facility em-
12
ployees who have recovered from COVID–19; 
13
and 
14
(H) the number of correctional facility em-
15
ployees who have died from a case of COVID– 
16
19. 
17
(4) RELEASE
OF
INCARCERATED
PERSONS.— 
18
Data related to the release of incarcerated persons, 
19
including individuals released to home confinement 
20
and pursuant to compassionate release, as a result 
21
of the COVID–19 public health emergency. 
22
(5) DAILY POPULATION.—Average daily popu-
23
lation, disaggregated by incarcerated persons and 
24
correctional facility employees. 
25
02:56 Jun 02, 2021
H2293
18 
•HR 2293 IH
(6) VACCINATIONS.—Data related to distribu-
1
tion of the COVID–19 vaccine, including— 
2
(A) the policies of the facility relating to 
3
the distribution of the COVID–19 vaccination 
4
to incarcerated persons and correctional facility 
5
staff, including how the facility is prioritizing 
6
distribution, both among correctional facility 
7
staff and incarcerated persons, and any changes 
8
or updates made to the policies; 
9
(B) the total number of COVID–19 vac-
10
cine doses that the facility has received up to 
11
the date of the report; 
12
(C) the total number and percentage of in-
13
carcerated persons who— 
14
(i) have been offered a COVID–19 
15
vaccine; 
16
(ii) have received a first dose of the 
17
COVID–19 vaccine up to the date of the 
18
report; 
19
(iii) are fully vaccinated, either be-
20
cause the person received a second dose of 
21
the COVID–19 vaccine or because the 
22
COVID–19 vaccine the person received re-
23
quired only 1 dose; 
24
02:56 Jun 02, 2021
H2293
19 
•HR 2293 IH
(iv) declined the COVID–19 vaccine; 
1
and 
2
(v) are housed in a skilled nursing 
3
level housing unit or hospice and have— 
4
(I) not received the COVID–19 
5
vaccine; 
6
(II) accepted the COVID–19 vac-
7
cine; and 
8
(III) declined the COVID–19 
9
vaccine; 
10
(D) the total number and percentage of 
11
correctional facility staff who— 
12
(i) have been offered a COVID–19 
13
vaccine; 
14
(ii) have received a first dose of the 
15
COVID–19 vaccine in up to the date of the 
16
report; 
17
(iii) are fully vaccinated, either be-
18
cause the person received a second dose of 
19
the COVID–19 vaccine or because the 
20
COVID–19 vaccine the person received re-
21
quired only 1 dose; and 
22
(iv) declined the COVID–19 vaccine; 
23
and 
24
02:56 Jun 02, 2021
H2293
20 
•HR 2293 IH
(E) in the case of incarcerated persons and 
1
correctional facility staff described in subpara-
2
graph (C)(iv) or (D)(iv), respectively, the 3 
3
most common reasons given for declining the 
4
COVID–19 vaccine. 
5
(b) DISAGGREGATION OF DATA.—The data described 
6
in this section shall be disaggregated by sex, sexual ori-
7
entation, gender identity, age, race, ethnicity, disability, 
8
and geography (including county and State). 
9
(c) PUBLIC REPORTING.—The Secretary of Health 
10
and Human Services, acting through the Director of the 
11
Centers for Disease Control and Prevention, shall make 
12
publicly available on the internet the most recent and his-
13
toric information reported weekly under subsection (a) in 
14
a machine-readable format. 
15
(d) COVID–19 SYMPTOM TRACKING AND MEDICAL 
16
RECORD RETENTION.—During the period beginning not 
17
later than 45 days after the date of enactment of this Act 
18
and ending on the last day of the COVID–19 pandemic, 
19
each correctional facility shall systemically track and 
20
record the signs and symptoms of COVID–19 among in-
21
carcerated persons and correctional center employees. As 
22
part of the tracking system, correctional facilities shall— 
23
(1) document and retain a record of each re-
24
quest from incarcerated persons for medical care, in-
25
02:56 Jun 02, 2021
H2293
21 
•HR 2293 IH
cluding medical care for the signs and symptoms of 
1
COVID–19; 
2
(2) conduct weekly screenings, in conjunction 
3
with the testing requirements described in section 3, 
4
of incarcerated persons for signs and symptoms of 
5
COVID–19 and maintain records of the results of 
6
such screenings for each incarcerated person; and 
7
(3) present for review, as requested at any time 
8
by the Secretary of Health and Human Services or 
9
the Attorney General, records collected under para-
10
graphs (1) and (2). 
11
(e) INCARCERATED PERSONS DATA.—The data de-
12
scribed in this section with respect to incarcerated persons 
13
who are serving a term of imprisonment and who are in-
14
fected with COVID–19 shall include, to the extent prac-
15
ticable, the term of imprisonment imposed on the incarcer-
16
ated persons, the time served, and the release date. 
17
(f) PRIVACY.—Any data collected, stored, received, or 
18
published under this section shall— 
19
(1) be so collected, stored, received, or pub-
20
lished in a manner that protects the privacy of indi-
21
viduals whose information is included in the data; 
22
(2) be de-identified or anonymized in a manner 
23
that protects the identity of all individuals whose in-
24
formation is included in the data; 
25
02:56 Jun 02, 2021
H2293
22 
•HR 2293 IH
(3) comply with privacy protections provided 
1
under the regulations promulgated under section 
2
264(c) of the Health Insurance Portability and Ac-
3
countability Act of 1996 (42 U.S.C. 1320d–2 note); 
4
and 
5
(4) be limited in use for the purpose of public 
6
health and be protected from all other internal use 
7
by any entity that collects, stores, or receives the 
8
data, including use of such data in determinations of 
9
eligibility (or continued eligibility) in health plans, 
10
and from any other inappropriate uses. 
11
(g) AUTHORIZATION OF APPROPRIATIONS.—There is 
12
authorized to be appropriated to the Centers for Disease 
13
Control and Prevention such sums as are necessary to 
14
publicize the data as described in this section. 
15
SEC. 5. CENTERS FOR DISEASE CONTROL AND INVESTIGA-
16
TION DEPLOYMENT. 
17
(a) IN GENERAL.—Correctional facilities shall report 
18
to the Centers for Disease Control and Prevention in-
19
stances when 3 or more incarcerated persons or correc-
20
tional facility employees present new COVID–19 cases 
21
within 72 hours of each other, within 24 hours of identi-
22
fying the third case. 
23
(b) DEPLOYMENT OF STAFF.—In such instances, the 
24
Centers for Disease Control and Prevention shall deploy 
25
02:56 Jun 02, 2021
H2293
23 
•HR 2293 IH
staff with experience in preventing the spread of infectious 
1
diseases in congregate settings to the facility for the pur-
2
pose of mitigating and preventing the spread of COVID– 
3
19 at the facility. 
4
SEC. 6. UPDATED BUREAU OF PRISONS GUIDELINES ON 
5
HANDLING COVID–19 IN CORRECTIONAL FA-
6
CILITIES. 
7
(a) UPDATED COVID–19 GUIDELINES.—Not later 
8
than 30 days after the date of enactment of this Act, the 
9
Department of Justice, acting through the Bureau of Pris-
10
ons and in consultation with the Centers for Disease Con-
11
trol and Prevention, shall release updated guidelines on 
12
the management of COVID–19 in correctional facilities. 
13
(b) EXPERT CONSULTATION.— 
14
(1) IN GENERAL.—In developing the guidelines 
15
described in subsection (a), the Department of Jus-
16
tice shall consult with no fewer than 10 experts in 
17
public health and correctional facility management, 
18
which shall include— 
19
(A) academics with medical and public 
20
health expertise; 
21
(B) advocates for imprisoned populations; 
22
(C) public health officials; 
23
(D) tribal leaders or their representatives; 
24
and 
25
02:56 Jun 02, 2021
H2293
24 
•HR 2293 IH
(E) labor representatives of correctional fa-
1
cility employees. 
2
(2) PUBLICLY
AVAILABLE.—Recommendations 
3
from and correspondence with individuals described 
4
in paragraph (1) shall be made publicly available. 
5
(c) CONTENTS.—The guidelines described in sub-
6
section (a) shall, at a minimum, include— 
7
(1) requirements that correctional facilities con-
8
duct voluntary COVID–19 diagnostic tests on, and 
9
quarantine consistent with Centers for Disease Con-
10
trol and Prevention guidance all new incarcerated 
11
persons who enter the facility during the COVID–19 
12
pandemic, including incarcerated persons being held 
13
at the facility while in transit between other facili-
14
ties; 
15
(2) guidance on how facilities should conduct 
16
weekly testing of incarcerated persons and correc-
17
tional facility employees, including guidance on how 
18
to conduct pooled sample testing in lieu of individual 
19
testing, if appropriate, and guidance on how to iden-
20
tify the appropriate type of diagnostic test to use, 
21
consistent with the most up-to-date public health in-
22
formation and guidance on preventing the spread of 
23
COVID–19; 
24
02:56 Jun 02, 2021
H2293
25 
•HR 2293 IH
(3) guidance on how correctional facilities 
1
should handle incarcerated persons who refuse to re-
2
ceive COVID–19 tests, such as through imple-
3
menting time-based or symptom-based isolation and 
4
quarantine strategies; 
5
(4) requirements that correctional facilities, 
6
once a single case of COVID–19 is detected within 
7
the facility, screen every incarcerated person and 
8
correctional facility employee for signs and symp-
9
toms of COVID–19 within 24 hours; 
10
(5) guidance for correctional facilities on max-
11
imum occupational capacity, social distancing best 
12
practices, and how to reduce the incarcerated person 
13
population within the facility, including updated 
14
guidance on the proactive release of incarcerated 
15
persons, with special consideration given to high-risk 
16
incarcerated persons; 
17
(6) guidance for correctional facilities on how to 
18
establish and implement cohorting strategies to min-
19
imize the spread of COVID–19 in facilities, with 
20
special consideration given to the cohorting of high- 
21
risk incarcerated persons; 
22
(7) guidance for correctional facilities on how to 
23
establish and implement contact tracing efforts to 
24
identify, track, and prevent the spread of COVID– 
25
02:56 Jun 02, 2021
H2293
26 
•HR 2293 IH
19 among the contacts of incarcerated persons and 
1
correctional facility employees who test positive for 
2
COVID–19; 
3
(8) guidance for correctional facilities on how 
4
to— 
5
(A) humanely and effectively quarantine 
6
incarcerated persons exposed to COVID–19 and 
7
humanely and effectively medically isolate and 
8
provide medical care to incarcerated persons 
9
who contract COVID–19, including a prohibi-
10
tion on the use of punitive solitary confinement 
11
and other punitive measures as a means of 
12
treating and medically isolating incarcerated 
13
persons, with special consideration given to the 
14
quarantining and medical isolation and treat-
15
ment of high-risk incarcerated persons; 
16
(B) authorize the provision of materials, 
17
such as books, television shows, magazines, and 
18
movies to, increase recreation hours for, and ex-
19
pand programming and phone and email com-
20
munication privileges for incarcerated persons 
21
in medical isolation to minimize the similarity 
22
of punitive solitary confinement and other puni-
23
tive measures with medical quarantine; and 
24
02:56 Jun 02, 2021
H2293
27 
•HR 2293 IH
(C) confirm that incarcerated persons and 
1
correctional facility employees who have con-
2
tracted COVID–19 have recovered for the pur-
3
pose of releasing them from medical isolation; 
4
(9) guidance for correctional facilities on the 
5
proper cleaning and disinfecting of the facility to 
6
prevent the spread of COVID–19; 
7
(10) guidance for correctional facilities on prop-
8
er ventilation and air filtration strategies to prevent 
9
the spread of COVID–19; 
10
(11) guidance on the proper daily, weekly, and 
11
monthly allowance for incarcerated persons of per-
12
sonal protective equipment and face coverings, hand 
13
sanitizer, soap, cleaning items, and other materials 
14
that could reduce the spread of COVID–19 in facili-
15
ties, which shall be provided to incarcerated persons 
16
at no cost, including information on how to update 
17
existing guidelines within facilities on the limitation 
18
of incarcerated persons’ access to such materials; 
19
(12) guidance for correctional facilities on how 
20
to educate incarcerated persons, and the medical fa-
21
cilities treating those incarcerated persons for 
22
COVID–19, on the healthcare rights of the incarcer-
23
ated persons under Federal and State law and the 
24
minimum ethical standards of care, including the 
25
02:56 Jun 02, 2021
H2293
28 
•HR 2293 IH
use of medical isolation that does not include soli-
1
tary confinement; 
2
(13) recommendations for correctional facilities 
3
on how to increase communication between incarcer-
4
ated persons and friends and family outside of the 
5
facility during the COVID–19 pandemic, including 
6
guidance on how to suspend fees for phone calls and 
7
electronic communications and expand visitation (in-
8
cluding virtual visitation) options; 
9
(14) requirements that correctional facilities 
10
communicate, not less frequently than biweekly, and 
11
in such a manner that permits for feedback from in-
12
carcerated persons, to incarcerated persons the steps 
13
being taken to address the COVID–19 pandemic in 
14
the facility; 
15
(15) guidance for correctional facilities on how 
16
to connect incarcerated persons released from con-
17
finement as a result of the COVID–19 pandemic 
18
with post-release resources, such as health insur-
19
ance, primary care providers, other health profes-
20
sionals, and quarantine facilities, with sensitivity to 
21
the immigration status of incarcerated persons; and 
22
(16) guidance for correctional facilities on how 
23
to equitably distribute COVID–19 vaccinations to in-
24
carcerated persons and correctional facility staff, 
25
02:56 Jun 02, 2021
H2293
29 
•HR 2293 IH
with the goal of maximizing COVID–19 safety with-
1
in correctional facilities and reducing health dispari-
2
ties among correctional facility populations. 
3
SEC. 7. REPORT TO CONGRESS. 
4
Not later than 60 days after the date of enactment 
5
of this Act, the Attorney General shall submit to Congress 
6
a report on prevention, mitigation, and control activities 
7
relating to the spread of COVID–19 in prisons conducted 
8
by the Department of Justice and the Bureau of Prisons, 
9
disaggregated by facility when applicable, that includes in-
10
formation on— 
11
(1) efforts of correctional facilities to comply 
12
with the Interim Guidance on Management of 
13
Coronavirus Disease 2019 (COVID–19) in Correc-
14
tional and Detention Facilities issued by the Centers 
15
for Disease Control and Prevention (referred to in 
16
this section as the ‘‘Interim Guidelines’’), includ-
17
ing— 
18
(A) information on steps that have been 
19
and continue to be taken with respect to oper-
20
ational preparedness, including— 
21
(i) with respect to communication and 
22
coordination— 
23
(I) developing information shar-
24
ing systems with partners; 
25
02:56 Jun 02, 2021
H2293
30 
•HR 2293 IH
(II) reviewing and revising for 
1
COVID–19 existing influenza, all-haz-
2
ards, and disaster plans; 
3
(III) coordinating with local law 
4
enforcement and court officials as 
5
necessary; and 
6
(IV) encouraging all persons in 
7
the facility, including through posting 
8
signs, to take action to protect them-
9
selves from COVID–19; 
10
(ii) with respect to personnel prac-
11
tices— 
12
(I) reviewing sick leave policies of 
13
each employer that operates within 
14
the facility; 
15
(II) identifying duties that can be 
16
performed remotely; 
17
(III) planning for staff absences; 
18
(IV) offering revised duties to 
19
staff at increased risk for severe ill-
20
ness from COVID–19; 
21
(V) making plans to change staff 
22
duty assignments to prevent unneces-
23
sary movement between housing units 
24
during a COVID–19 outbreak; 
25
02:56 Jun 02, 2021
H2293
31 
•HR 2293 IH
(VI) offering the seasonal influ-
1
enza vaccines to all incarcerated per-
2
sons and correctional facility staff; 
3
and 
4
(VII) offering and administering 
5
COVID–19 vaccines to all incarcer-
6
ated persons and correctional facility 
7
staff; and 
8
(iii) with respect to operations, sup-
9
plies, and personal protective equipment 
10
(referred to in this clause as ‘‘PPE’’) prep-
11
arations— 
12
(I) ensuring that sufficient stocks 
13
of hygiene supplies, cleaning supplies, 
14
PPE, and medical supplies (consistent 
15
with the healthcare capabilities of the 
16
facility) are on hand and available, 
17
and having a plan in place to restock 
18
as needed; 
19
(II) making contingency plans for 
20
possible PPE shortages during the 
21
COVID–19 pandemic; 
22
(III) relaxing restrictions on al-
23
lowing alcohol-based hand sanitizer; 
24
02:56 Jun 02, 2021
H2293
32 
•HR 2293 IH
(IV) providing a no-cost supply 
1
of soap to incarcerated persons suffi-
2
cient to allow frequent hand washing; 
3
(V) establishing a respiratory 
4
protection program, if not already in 
5
place; 
6
(VI) ensuring that correctional 
7
facility staff and incarcerated persons 
8
are trained to correctly don, doff, and 
9
dispose of PPE that they will need to 
10
use within the scope of their respon-
11
sibilities; and 
12
(VII) setting up designated PPE 
13
donning and doffing areas outside all 
14
spaces where PPE will be used; 
15
(B) information on steps that have been 
16
and continue to be taken with respect to pre-
17
vention, including— 
18
(i) to prevent COVID–19 cases among 
19
incarcerated persons— 
20
(I) implementing social distanc-
21
ing strategies to increase the physical 
22
space between incarcerated persons, 
23
which, to the extent practicable, shall 
24
02:56 Jun 02, 2021
H2293
33 
•HR 2293 IH
be 6 feet between all individuals, re-
1
gardless of symptoms; 
2
(II) minimizing the mixing of in-
3
dividuals from different housing units; 
4
and 
5
(III) providing up-to-date infor-
6
mation about COVID–19 to incarcer-
7
ated persons; 
8
(ii) to prevent COVID–19 cases 
9
among correctional facility staff— 
10
(I) reminding staff to stay at 
11
home if they are sick; 
12
(II) performing verbal screening 
13
and temperature checks for all staff 
14
daily upon entry; and 
15
(III) providing up-to-date infor-
16
mation about COVID–19 to staff, in-
17
cluding information about sick leave 
18
policies; and 
19
(iii) to prevent COVID–19 cases 
20
among visitors— 
21
(I) communicating with potential 
22
visitors to discourage contact visits; 
23
02:56 Jun 02, 2021
H2293
34 
•HR 2293 IH
(II) conducting verbal screenings 
1
and temperature checks for visitors, 
2
and requiring face coverings; and 
3
(III) promoting non-contact visits 
4
and providing access to free virtual 
5
visitation options; 
6
(C) information on steps that have been 
7
and continue to be taken with respect to 
8
COVID–19 case management, including— 
9
(i) with respect to infection control, 
10
ensuring proper infection control protocols 
11
are in place; 
12
(ii) with respect to medical isolation— 
13
(I) placing incarcerated individ-
14
uals with confirmed or suspected 
15
cases of COVID–19 in medical isola-
16
tion; 
17
(II) ensuring that medical isola-
18
tion for COVID–19 is distinct from 
19
punitive solitary confinement; 
20
(III) keeping to an absolute min-
21
imum the movement outside the med-
22
ical isolation space of incarcerated in-
23
dividuals with confirmed or suspected 
24
cases of COVID–19; and 
25
02:56 Jun 02, 2021
H2293
35 
•HR 2293 IH
(IV) safely cohorting, if nec-
1
essary, COVID–19-infected incarcer-
2
ated individuals; and 
3
(iii) with respect to provision of 
4
care— 
5
(I) ensuring that incarcerated 
6
persons receive medical evaluation and 
7
treatment at the first signs of 
8
COVID–19 symptoms, including in 
9
cases where a facility is not able to 
10
provide such evaluation and treatment 
11
onsite; 
12
(II) providing incarcerated indi-
13
viduals with onsite healthcare; and 
14
(III) providing incarcerated indi-
15
viduals with healthcare services in the 
16
community, as necessary; and 
17
(D) all other aspects of the Interim Guid-
18
ance; 
19
(2) the process for determining which incarcer-
20
ated persons qualify for home confinement, including 
21
listing every factor that is taken into consideration, 
22
and how the factors are weighed to determine quali-
23
fication, including— 
24
02:56 Jun 02, 2021
H2293
36 
•HR 2293 IH
(A) how many incarcerated persons have 
1
been reviewed for home confinement; 
2
(B) how many incarcerated persons have 
3
qualified for and have been moved into home 
4
confinement, and the average length of time be-
5
tween review, approval, and transfer; 
6
(C) how the prior convictions of an incar-
7
cerated person are used to determine who quali-
8
fies for home confinement, including whether 
9
certain convictions are weighed more heavily 
10
than others, and whether a prior conviction re-
11
gardless of severity automatically bars an incar-
12
cerated person from qualifying for home con-
13
finement; and 
14
(D) demographic data of the incarcerated 
15
persons who are considered for home confine-
16
ment and of the incarcerated persons who are 
17
ultimately 
chosen 
for 
home 
confinement, 
18
disaggregated by age, race, gender, ethnicity, 
19
level of offense, how much time remains on 
20
their sentence, and whether the individual is 
21
high risk for COVID–19; 
22
(3) the process for determining which incarcer-
23
ated persons qualify for compassionate release, in-
24
cluding listing every factor that is taken into consid-
25
02:56 Jun 02, 2021
H2293
37 
•HR 2293 IH
eration, and how the factors are weighed to deter-
1
mine qualification, including— 
2
(A) how many incarcerated persons have 
3
been reviewed for compassionate release; 
4
(B) how many incarcerated persons have 
5
qualified 
for 
compassionate 
release, 
6
disaggregated by compassionate releases ap-
7
proved by the Bureau of Prisons and compas-
8
sionate releases granted by courts, and the av-
9
erage length of time between review, approval, 
10
and release; 
11
(C) how the prior convictions of an incar-
12
cerated person are used to determine who quali-
13
fies for compassionate release, including wheth-
14
er certain convictions are weighed more heavily 
15
than others, and whether a prior conviction re-
16
gardless of severity automatically bars an incar-
17
cerated person from qualifying for compas-
18
sionate release; and 
19
(D) demographic data of the incarcerated 
20
persons who are considered for compassionate 
21
release and of the incarcerated persons who are 
22
ultimately chosen for compassionate release, 
23
disaggregated by age, race, gender, ethnicity, 
24
02:56 Jun 02, 2021
H2293
38 
•HR 2293 IH
level of offense, and how much time remains on 
1
their sentence; 
2
(4) the process of providing information to fam-
3
ilies and emergency contacts of incarcerated persons 
4
who have tested positive for COVID–19, including 
5
how long it takes on average for families and emer-
6
gency contacts to be notified after initial diagnosis, 
7
and how often facilities follow up with families and 
8
emergency contacts to update them on the health 
9
condition of the incarcerated person; 
10
(5) resource limitations, if any, that have inhib-
11
ited the ability of the Department of Justice and 
12
Bureau of Prisons to fully implement the Centers 
13
for Disease Control and Prevention’s Interim Guide-
14
lines; and 
15
(6) what actions are being taken to modernize 
16
the electronic health records systems of the Bureau 
17
of Prisons. 
18
Æ 
02:56 Jun 02, 2021
H2293
